The Geriatric Emergency Department Pharmacologic Harm Prevention Project
Recruiting
N/A
Interventional Study
Fall
Fall Accident
Poly Pharmacy
Adverse Drug Events
Pharmacogenomic Drug Interaction
Pharmacogenomic Testing
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 65 – 110
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 1,000 (estimated)
- Sponsor
- Florida Atlantic University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this project is to determine whether pharmacogenomic testing (using participants' DNA) can help optimize medication prescribing and reduce side effects in older adults taking five or more medications.
The main questions it aims to answer are:
* Can DNA-based prescribing reduce medication-related side effects, especially falls and fall-related injuries?
* Does providing pharmacogenomi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients over the age of 65 with a ground level fall
Exclusion Criteria:
* hospice and/or DNR status.
Contacts